Skip to main content
logo
Restart Life Sciences Corp. (CSE:HEAL)
Canada flag Canada · Delayed Price · Currency is CAD
0.0750
+0.0050 (7.14%)
Aug 10, 2026, 10:44 AM EST

Restart Life Sciences Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.13-----
Revenue Growth
------
Gross Profit
0.06-----0.01
Operating Income
-0.94-1.3-0.63-1.21-1.85-2.8
Net Income
-0.9-1.390.22-1.22-2.47-2.68
Earnings Per Share
-0.03-0.040.01-0.08-0.18-0.24
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.191.650.170.010.270.22
Total Debt
0.350.250.08---
Net Cash (Debt)
0.841.410.090.010.270.22
Net Cash Growth
115.06%1535.88%963.58%-96.97%21.85%-89.78%
Net Cash Per Share
0.020.040.010.000.020.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.56-0.72-0.07-0.28-2.41-1.95
Capital Expenditures
------
Free Cash Flow
-0.56-0.72-0.07-0.28-2.41-1.95
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
46.03%-----
Operating Margin
-701.77%-----
Profit Margin
-667.34%-----
FCF Margin
-413.25%-----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--4.81---
PS Ratio
32.44-----